February 9, 2021-February 10, 2021 SHIP-MD 2021 Virtual Workshop Join Us February 9th, 10th, 11th 2021 Free Public Virtual Meeting and Workshop All stakeholders interested in pediatric medical de
February 4, 2021 C-Path Appoints Co-Directors to CURE Drug Repurposing Collaboratory Advisory Committee TUCSON, Ariz., February 4, 2021 — Critical Path Institute (C-Path) today has announced the appointments of David F
January 21, 2021-February 9, 2024 Watch now: RDCA-DAP and EATRIS Present Rare Disease Drug Develoment Webinar January 21, 2021 | 5:00 p.m. – 6:30 p.m. CET Data Sharing and Analysis to Support Rare Disease Drug Development The Europ
January 14, 2021 C-Path Announces SHIP-MD 2021 Virtual Workshop Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development TUCSON, Ariz.,
January 8, 2021 Effective Data Sharing as a Conduit for Advancing Medical Product Development Patient-level data sharing has the potential to significantly impact the lives of patients by optimizing and improving the medical
January 7, 2021 Diary for Irritable Bowel Syndrome Symptoms-Constipation is the First Patient-Reported Outcome Consortium Measure Used to Support an FDA-approved Label Claim TUCSON, Ariz., January 7, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces th
December 16, 2020 C-Path and Diamyd Medical Announce Data Sharing Collaboration to Develop Advanced Drug Development Tools in Type 1 Diabetes TUCSON, Ariz., and STOCKHOLM, Sweden. December 16, 2020 — The Critical Path Institute (C-Path) and Diamyd Medical
December 3, 2020 C-Path Selects Aridhia to Support Rare Disease Cures Accelerator-Data and Analytics Platform TUCSON, Ariz., December 3, 2020 — The Critical Path Institute (C-Path) today announced it has selected Aridhia to support
December 3, 2020 C-Path, Ltd. Announces New Contract with Innovative Medicines Initiative DUBLIN, Ireland, December 3, 2020 — Critical Path Institute, Ltd. (C-Path, Ltd.) announced today a new contract with the